Dariusz Kowalski

Dariusz Kowalski

UNVERIFIED PROFILE

Are you Dariusz Kowalski?   Register this Author

Register author
Dariusz Kowalski

Dariusz Kowalski

Publications by authors named "Dariusz Kowalski"

Are you Dariusz Kowalski?   Register this Author

43Publications

1183Reads

12Profile Views

Population morbidity in elderly lung cancer patients from Poland with specific trends in elderly women.

Prz Menopauzalny 2019 Dec 20;18(3):161-165. Epub 2019 Dec 20.

Department of Management and Logistics in Health Care, Medical University of Lodz, Lodz, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5114/pm.2019.90811DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6970423PMC
December 2019

Solitary fibrous tumour along with non-small-cell lung cancer and Doege-Potter syndrome.

Kardiochir Torakochirurgia Pol 2019 Mar 4;16(1):49-51. Epub 2019 Apr 4.

Department of Lung Cancer and Chest Tumours, Maria Skłodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5114/kitp.2019.83948DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491374PMC
March 2019

Preventing central nervous system metastases in non-small cell lung cancer.

Expert Rev Anticancer Ther 2018 11 21;18(11):1077-1083. Epub 2018 Sep 21.

a Department of Pneumonology , Oncology and Allergology, Medical University of Lublin , Lublin , Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14737140.2018.1521273DOI Listing
November 2018

Pembrolizumab plus Chemotherapy for Squamous Non-Small-Cell Lung Cancer.

N Engl J Med 2018 11 25;379(21):2040-2051. Epub 2018 Sep 25.

From Hospital Universitario 12 de Octubre, Spanish National Cancer Research Center, Universidad Complutense and Ciberonc, Madrid (L.P.-A.), and Hospital Universitario Virgen Macarena, Seville (D.V.) - both in Spain; Leningrad Regional Clinical Hospital, St. Petersburg, Russia (A.L.); Wollongong Oncology and Wollongong Private Hospital, Wollongong, NSW, Australia (A.T.); Istanbul Medeniyet University Hospital, Istanbul (M.G.), and Ankara University, Ankara (F.Ç.Ş.) - both in Turkey; Centre Hospitalier Universitaire de Toulouse, Université Paul Sabatier, Toulouse, France (J.M.); Universitätsklinikum Tübingen, Tübingen, Germany (B. Hermes); Jász-Nagykun-Szolnok County Hospital, Szolnok (T.C.), and Országos Korányi TBC és Pulmonológiai Intézet, Budapest (A.F.) - both in Hungary; Oncology Center, Medica Sur Hospital, Mexico City (J.R.-C.); Humber River Regional Hospital, Toronto (J.W.); Sendai Kousei Hospital, Sendai (S.S.), and the Kanagawa Cancer Center, Yokohama (T.K.) - both in Japan; Chungbuk National University Hospital, Chungbuk National University College of Medicine, Cheong-ju, South Korea (K.H.L.); Jilin Cancer Hospital, Changchun, China (Y.C.); University of Turin, Orbassano, Italy (S.N.); Montefiore Medical Center-Albert Einstein College of Medicine, New York (B. Halmos); Merck, Kenilworth, NJ (X.L., G.M.L., B.P.); and the Maria Skłodowska-Curie Institute of Oncology, Warsaw, Poland (D.M.K.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1810865DOI Listing
November 2018

Evaluation of miR-506 and miR-4316 expression in early and non-invasive diagnosis of colorectal cancer.

Int J Colorectal Dis 2017 Jul 12;32(7):1057-1060. Epub 2017 Apr 12.

Department of Pneumonology, Oncology and Allergology, Medical University of Lublin, Jaczewskiego 8, 20-954, Lublin, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00384-017-2814-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5486640PMC
July 2017

A decrease in D-dimer concentration and an occurrence of skin rash as iatrogenic events and complementary predictors of survival in lung cancer patients treated with EGFR tyrosine kinase inhibitors.

Pharmacol Rep 2016 Dec 20;68(6):1140-1148. Epub 2016 Jul 20.

Department of Pulmonary Circulation and Thromboembolic Diseases, Centre of Postgraduate Medical Education, European Health Centre Otwock, Otwock, Poland. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.pharep.2016.07.003DOI Listing
December 2016

Application of plasma circulating microRNA-448, 506, 4316, and 4478 analysis for non-invasive diagnosis of lung cancer.

Tumour Biol 2016 Feb 4;37(2):2049-55. Epub 2015 Sep 4.

Department of Pneumonology, Oncology, and Allergology, Medical University of Lublin, Jaczewskiego 8, 20-954, Lublin, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s13277-015-3971-4DOI Listing
February 2016

Plasma circulating microRNA-944 and microRNA-3662 as potential histologic type-specific early lung cancer biomarkers.

Transl Res 2015 Oct 29;166(4):315-23. Epub 2015 May 29.

Department of Pneumonology, Oncology and Allergology, Medical University of Lublin, Lublin, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.trsl.2015.05.009DOI Listing
October 2015

Structure and microbial diversity of biofilms on different pipe materials of a model drinking water distribution systems.

World J Microbiol Biotechnol 2015 Jan 24;31(1):37-47. Epub 2014 Oct 24.

Department of Water Supply and Sewage Disposal, Faculty of Environmental Engineering, Lublin University of Technology, ul. Nadbystrzycka 40B, 20-618, Lublin, Poland,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11274-014-1761-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4282696PMC
January 2015

Correlation between TS, MTHFR, and ERCC1 gene polymorphisms and the efficacy of platinum in combination with pemetrexed first-line chemotherapy in mesothelioma patients.

Clin Lung Cancer 2014 Nov 15;15(6):455-65. Epub 2014 Aug 15.

Department of Pneumonology, Oncology and Allergology, Medical University of Lublin, Lublin, Poland; Institute of Agricultural Medicine of Lublin, Lublin, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2014.06.009DOI Listing
November 2014

Evaluation of antitumor activity using change in tumor size of the survivin antisense oligonucleotide LY2181308 in combination with docetaxel for second-line treatment of patients with non-small-cell lung cancer: a randomized open-label phase II study.

J Thorac Oncol 2014 Nov;9(11):1704-8

*Cedars-Sinai Medical Center, Los Angeles, California; †The Lung Cancer Group, The Christie and University Hospital of South Manchester, Manchester, United Kingdom; ‡Memorial Cancer Centre of Oncology and Institute Department of Lung Cancer and Chest Tumours, Warsaw, Poland; §Poznań University of Medical Sciences, Wielkopolskie Centrum Pulmonologii i Torakochirurgii, Poznań, Poland; ‖Karmanos Cancer Center, Detroit, Michigan; ¶Lung Cancer Unit, IRCCS AOU San Martino IST, Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy; #Gemeinschaftspraxis für Haematologie, Onkologie und Palliativmedizin, Münster, Germany; **Department of Thoracic Oncology, H. Lee Moffitt Cancer Center, Tampa, Florida; ††St. Vincentius-Kliniken gAG - Med. Klinik Abt. 2, Karlsruhe, Germany; ‡‡Sheffield Experimental Cancer Medicine Centre, Academic Unit of Clinical Oncology, University of Sheffield, Weston Park Hospital, Sheffield, United Kingdom; §§Internal Medicine, Karmanos Cancer Institute, Detroit, Michigan; ‖‖Eli Lilly and Company, Windlesham, United Kingdom; ¶¶Eli Lilly and Company, Basingstoke, Hampshire, United Kingdom; ##Eli Lilly and Company, Indianapolis, Indiana; and ***Department of Oncology, University of Oxford, Cancer and Haematology Center, Churchill Hospital, Oxford, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0000000000000285DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4340255PMC
November 2014

EGFR mutation testing on cytological and histological samples in non-small cell lung cancer: a Polish, single institution study and systematic review of European incidence.

Int J Clin Exp Pathol 2013 15;6(12):2800-12. Epub 2013 Nov 15.

Department of Diagnostic Hematology, Institute of Hematology and Transfusion Medicine Warsaw ; Department of Pathology, Maria Skłodowska-Curie Memorial Cancer Centre and Institute of Oncology Warsaw.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3843260PMC
August 2014

DISRUPT: a randomised phase 2 trial of ombrabulin (AVE8062) plus a taxane-platinum regimen as first-line therapy for metastatic non-small cell lung cancer.

Lung Cancer 2014 Aug 21;85(2):224-9. Epub 2014 May 21.

IRCCS AOU San Martino IST, Istituto Nazionale per la Ricerca sul Cancro, Largo R. Benzi 10, 16132 Genova, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2014.05.013DOI Listing
August 2014

Genetic and immune factors underlying the efficacy of cetuximab and panitumumab in the treatment of patients with metastatic colorectal cancer.

Contemp Oncol (Pozn) 2014 14;18(1):7-16. Epub 2013 Nov 14.

Department of Lung Cancer and Thoracic, Oncology Centre - Maria Skłodowska-Curie Institute, Warsaw, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5114/wo.2013.38566DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4037996PMC
June 2014

Prognostic value of synaptophysin and chromogranin a expression in patients receiving palliative chemotherapy for advanced non-small-cell lung cancer.

Respiration 2013 3;85(4):289-96. Epub 2012 Apr 3.

Department of Lung Cancer and Chest Tumors, Maria Skłodowska-Curie Memorial Cancer Center and Institute, Warsaw, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000337090DOI Listing
October 2013

Erlotinib in salvage treatment of patients with advanced non-small cell lung cancer: results of an expanded access programme in Poland.

Contemp Oncol (Pozn) 2012 29;16(2):170-5. Epub 2012 May 29.

The Maria Sklodowska-Curie Memorial Cancer Centre and Institute, Department of Lung Cancer and Chest Tumours, Warsaw, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5114/wo.2012.28798DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3687401PMC
June 2013

Mechanisms of resistance to reversible inhibitors of EGFR tyrosine kinase in non-small cell lung cancer.

Contemp Oncol (Pozn) 2012 20;16(5):401-6. Epub 2012 Nov 20.

Department of Pneumonology, Oncology and Allergology, Medical University of Lublin, Lublin, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5114/wo.2012.31768DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3687444PMC
June 2013

[Gefitinib in patients with advanced non-small-cell lung cancer].

Pneumonol Alergol Pol 2012 ;80(5):439-49

Klinika Nowotworów Płuca i Klatki Piersiowej, Centrum Onkologii--Instytut, ul. Roentgena 5,02–781 Warszawa.

View Article

Download full-text PDF

Source
February 2013

The qualification of docetaxel or erlotinib for second-line therapy should be based on clinical and molecular predictive factors.

Chemotherapy 2012 16;58(1):60-9. Epub 2012 Feb 16.

Department of Pneumonology, Oncology and Allergology, Medical University of Lublin, Lublin, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000336143DOI Listing
July 2012

The applicability of a predictive index for second- and third-line treatment of unselected non-small-cell lung cancer patients.

Respiration 2011 18;82(4):341-50. Epub 2011 Jan 18.

Department of Pneumonology, Oncology and Allergology, Medical University, Lublin, Poland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000322843DOI Listing
January 2012